VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener
ScreenerThemes
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
Earnings
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Pharma & Energy
LLY vs NVOJNJ vs PFEXOM vs CVX
Compare Any Stocks...
WatchlistInsider
ScreenerThemes
Earnings
WatchlistInsider
COCP
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Verify deeply. Act with conviction.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly stock ideas — free

© 2026 VCP Scanner
AboutPrivacyTerms
Not financial advice. Do your own research.
ScreenerNewsCompareWatchlist
COCPCocrystal Pharma, Inc.
$1.02$10M
Overview & Verdict
Overview
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice HistoryTechnical Analysis
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Ownership
Holders
HomeStocksCOCPQuarterly Financials

Cocrystal Pharma, Inc. (COCP) Quarterly Financials

120+ quarters historyFree accessUpdated daily

Cocrystal Pharma, Inc. (COCP) quarterly income statement — complete revenue, gross profit & net income history

COCP Income Statement

Income StatementBalance SheetCash FlowRatios
AnnualQuarterly
MetricQ1'26Q4'25Q3'25Q2'25Q1'25Q4'24Q3'24Q2'24Q1'24Q4'23Q3'23Q2'23Q1'23Q4'22Q3'22Q2'22Q1'22Q4'21Q3'21Q2'21
Sales/Revenue225K0000000000000000000
Revenue Growth %------------------100%-100%-100%
Cost of Goods Sold91K-1.39M021K1.36M28K3.24M4.31M2.95M4.27M4.19M2.8M3.91M3.29M3.87M2.36M2.87M97K2.1M2.56M
COGS % of Revenue40.44%-------------------
Gross Profit134K1.39M0-21K-1.36M-28K-3.24M-4.31M-2.95M-4.27M-4.19M-2.8M-3.91M-3.29M-3.87M-2.36M-2.87M-97K-2.1M-2.56M
Gross Margin %59.56%-------------------
Gross Profit Growth %109.85%5078.57%100%99.51%53.9%99.34%22.7%-53.8%24.49%-29.81%-8.32%-18.64%-36.04%-3288.66%-83.94%7.67%-82.12%48.4%-32.56%-79.82%
Operating Expenses2.49M3.88M2.09M2.09M981K3.2M1.8M1.14M1.21M399K249K1.54M1.2M1.22M1.82M22.07M1.33M3.6M1.85M1.27M
OpEx % of Revenue1106.67%-------------------
Selling, General & Admin1.21M862K1.14M986K981K1.17M1.8M1.14M1.21M1.4M1.85M1.54M1.2M1.22M1.82M1.38M1.33M1.4M1.85M1.27M
SG&A % of Revenue537.78%-------------------
Research & Development1.37M1.62M954K1.12M1.36M2.04M3.24M4.31M2.95M4.27M4.19M2.8M3.91M3.29M3.87M2.36M2.87M2.21M2.1M2.56M
R&D % of Revenue609.33%-------------------
Other Operating Expenses-91K1000K0-21K-1000K0-1000K-1000K-1000K-1000K-1000K-1000K-1000K-1000K-1000K1000K-1000K0-1000K-1000K
Operating Income-2.36M-2.48M-2.09M-2.11M-2.34M-3.23M-5.04M-5.45M-4.16M-4.67M-4.44M-4.34M-5.11M-4.5M-5.69M-24.43M-4.21M-3.7M-3.95M-3.83M
Operating Margin %-1047.11%-------------------
Operating Income Growth %-0.64%23.19%58.57%61.31%43.7%30.78%-13.48%-25.56%18.65%-3.64%21.97%82.24%-21.55%-21.61%-44.04%-538.14%-53.58%-152.52%-45.92%-10.96%
EBITDA-2.27M-2.39M-1.85M-2.09M-2.32M-3.2M-5.01M-5.42M-4.12M-4.63M-4.39M-4.29M-5.06M-4.45M-5.65M-24.38M-4.16M-3.6M-3.9M-3.78M
EBITDA Margin %-1006.67%-------------------
EBITDA Growth %2.2%25.36%63.09%61.46%43.83%30.78%-14.17%-26.16%18.55%-3.86%22.26%82.4%-21.71%-23.55%-44.68%-544.91%-54.44%-153.69%-46.45%-10.81%
D&A (Non-Cash Add-back)91K91K239K21K25K28K30K33K35K40K53K47K49K48K47K44K46K97K50K47K
EBIT-2.36M-2.48M-2.09M-2.11M-2.34M-3.27M-5.04M-5.45M-4.16M-5.67M-6.04M-4.34M-5.11M-4.5M-5.69M-3.74M-4.21M-3.69M-3.95M-3.83M
Net Interest Income22K-87K22K28K37K55K111K151K220K180K320K140K-78K-1K-1K0-1K0-1K-2K
Interest Income22K-87K22K28K37K55K111K151K220K180K320K140K00000000
Interest Expense00000000-00078K1K1K01K01K2K
Other Income/Expense57K55K40K53K40K-36K103K105K202K202K278K173K-78K1K-6K0-3K17K12K7K
Pretax Income-2.3M-2.43M-2.05M-2.06M-2.3M-3.27M-4.94M-5.34M-3.96M-4.46M-4.17M-4.17M-5.19M-4.5M-5.7M-24.43M-4.21M-3.69M-3.94M-3.82M
Pretax Margin %-1021.78%-------------------
Income Tax00000000000000000000
Effective Tax Rate %0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%
Net Income-2.3M-2.43M-2.05M-2.06M-2.3M-3.27M-4.94M-5.34M-3.96M-4.46M-4.17M-4.17M-5.19M-4.5M-5.7M-24.43M-4.21M-3.69M-3.94M-3.82M
Net Margin %-1021.78%-------------------
Net Income Growth %0.09%25.72%58.51%61.54%41.84%26.84%-18.58%-28.25%23.76%0.82%26.93%82.95%-23.31%-22.14%-44.63%-539.31%-53.69%-146.82%-47.6%-9.33%
Net Income (Continuing)-2.3M-2.43M-2.05M-2.06M-2.3M-3.27M-4.94M-5.34M-3.96M-4.46M-4.17M-4.17M-5.19M-4.5M-5.7M-24.43M-4.21M-3.69M-3.94M-3.82M
Discontinued Operations00000000000000000000
Minority Interest00000000000000000000
EPS (Diluted)-0.17-0.18-0.19-0.20-0.23-0.32-0.49-0.53-0.39-0.44-0.41-0.41-0.65-0.55-0.70-5.55-0.52-0.51-0.48-0.53
EPS Growth %26.09%43.75%61.22%62.26%41.03%27.27%-19.51%-29.27%40%20%41.43%92.61%-25%-7.84%-45.83%-947.17%-13.04%-64.52%14.29%33.75%
EPS (Basic)-0.17-0.18-0.19-0.20-0.23-0.32-0.49-0.53-0.39-0.44-0.41-0.41-0.65-0.55-0.70-5.55-0.52-0.51-0.49-0.53
Diluted Shares Outstanding13.79M11.29M10.99M10.17M10.17M10.17M10.17M10.17M10.17M10.17M10.15M10.06M8.14M8.14M8.14M8.12M8.12M7.26M8.14M7.26M
Basic Shares Outstanding13.79M11.29M10.99M10.17M10.17M10.17M10.17M10.17M10.17M10.17M10.15M10.06M8.14M8.14M8.14M8.12M8.12M7.26M8.12M7.26M
Dividend Payout Ratio--------------------